AstraZeneca is looking at plans to spin off its Chinese businesses to protect it from geopolitical tension, according to a report.
Citing people familiar with the situation, the Financial Times said the British-Swedish drugs giant has been in talks with bankers for several months.The plan would separate Astra’s Chinese operations into a separate company whose shares would be ...
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
AstraZeneca ‘mulling split from Chinese business amid rising tensions’Drugs giant hopes to be better protected against political reprisals from Beijing against foreign companies
Leer más »
AstraZeneca drafts plan to spin off China business amid tensionsAnglo-Swedish drugmaker views listing a separate unit in Hong Kong as potential shelter from global strife via IrishTimesBiz
Leer más »